Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study
- 11 July 2021
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 100 (10) , 2621-2631
Abstract
Currently, acute graft-versus-host disease (aGVHD) diagnosis is based on clinical features and pathological findings. Until now, there is no non-invasive diagnostic test for aGVHD. MicroRNAs may act as promising predictive, diagnostic, or prognostic biomarkers for aGVHD. The purpose of the current study was to validate circulating microRNAs as diagnostic biomarkers to assist clinicians in promptly diagnosing aGVHD, so that treatment can be initiated earlier. In the present study, we evaluated six microRNAs (miR-455-3p, miR-5787, miR-6729-5p, miR-6776-5p, miR-548a-3p, and miR-6732-5p) selected from miRNA array data in 40 aGVHD patients compared to 40 non-GVHD patients with RT-qPCR. Target genes of differentially expressed microRNAs (DEMs) were predicted using Targetscan, miRanda, miRDB, miRWalk, PICTAR5, miRmap, DIANA, and miRTarBase algorithms, and their functions were analyzed using EnrichNet, Metascape, and DIANA-miRPath databases. The expressions of plasma miR-455-3p and miR-5787 were significantly downregulated, whereas miR-548a-3p was significantly upregulated in aGVHD patients compared to non-GVHD patients. Moreover, DEMs showed potentially high diagnostic accuracy for aGVHD. In silico analysis of DEMs provided valuable information on the role of DEMs in GVHD, immune regulation, and inflammatory response. Our study suggested that miR-455-3p, miR-5787, and miR-548a-3p could be used as potential noninvasive biomarkers in the diagnosis of aGVHD in addition to possible therapeutic targets in aGVHD.Keywords
Funding Information
- Tehran University of Medical Sciences and Health Services (95043633688)
- Mashhad University of Medical Sciences (971837)
This publication has 58 references indexed in Scilit:
- Graft-versus-host disease biomarkers: omics and personalized medicineInternational Journal of Hematology, 2013
- Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemiaBone Marrow Transplantation, 2012
- EnrichNet: network-based gene set enrichment analysisBioinformatics, 2012
- Advances in graft-versus-host disease biology and therapyNature Reviews Immunology, 2012
- The hsa-miR-5787 represses cellular growth by targeting eukaryotic translation initiation factor 5 (eIF5) in fibroblastsBiochemical and Biophysical Research Communications, 2011
- Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in miceBlood, 2011
- Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host diseaseBlood, 2011
- Graft-versus-host diseaseThe Lancet, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Graft-versus-host diseaseNature Reviews Immunology, 2007